483
Dayan K. Gandhi, M.D.Dayan K. Gandhi, M.D. – FDA 483, Jul 2, 2026
Record Details
An FDA inspection of Dayan K. Gandhi, M.D., a clinical investigator in Granada Hills, CA, revealed significant deviations from clinical trial protocols. The firm failed to administer investigational product according to the plan, improperly enrolled a subject, and did not ensure IP interruption when required. Additionally, the firm failed to promptly report two Serious Adverse Events to the study sponsor.
View Company Profile
ID · 46972669-af29-424a-ac8f-8c4db4bf088f
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.